MPhil Haematology and Leukaemia
Course Overview
This course provides a comprehensive overview of the pioneering haemato-oncology research conducted at the Liverpool Cancer Research UK Centre. It bridges the gap between foundational scientific discovery and clinical application, focusing on translating laboratory findings into innovative therapies for blood cancers. Participants will explore the centre's specific research strengths in Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), and lymphoproliferative disorders.
Key Program Highlights
- Examine the role of Protein Kinase C (PKC) and c-abl in B-cell receptor signalling for CLL development
- Explore the mechanisms of malignant cell survival in hairy cell leukemia, including PKC-dependent ERK activation
- Learn the process of translating both clinical and non-clinical studies into new therapeutic applications
- Gain insights from a centre with strong national leadership in key NCRI haematological oncology subgroups
- Understand the biology of disease to lay the scientific foundation for improved cancer therapies
Course Overview
This course provides a comprehensive overview of the pioneering haemato-oncology research conducted at the Liverpool Cancer Research UK Centre. It bridges the gap between foundational scientific discovery and clinical application, focusing on translating laboratory findings into innovative therapies for blood cancers. Participants will explore the centre's specific research strengths in Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), and lymphoproliferative disorders.
Key Program Highlights
- Examine the role of Protein Kinase C (PKC) and c-abl in B-cell receptor signalling for CLL development
- Explore the mechanisms of malignant cell survival in hairy cell leukemia, including PKC-dependent ERK activation
- Learn the process of translating both clinical and non-clinical studies into new therapeutic applications
- Gain insights from a centre with strong national leadership in key NCRI haematological oncology subgroups
- Understand the biology of disease to lay the scientific foundation for improved cancer therapies
